Triple therapy: Boon or bane for high-risk CV patients?

被引：0

作者：

Phillippe, Haley M. ^{[1
]}

Baty, Sharon R. ^{[2
]}

Griffith, Candace B. ^{[3
]}

机构：

[1] Univ Alabama, Birmingham Sch Med Huntsville, Harrison Sch Pharm, Auburn Univ, Huntsville, AL 35801 USA

[2] Huntsville Dist Mem Hosp, Huntsville, AL USA

[3] Enteral Parenteral Pharm, Huntsville, AL USA

来源：

JOURNAL OF FAMILY PRACTICE | 2011年 / 60卷 / 04期

关键词：

ATRIAL-FIBRILLATION; ANTIPLATELET THERAPY; ANTITHROMBOTIC THERAPY; CARDIOVASCULAR-DISEASE; BLEEDING RISK; ASPIRIN; WARFARIN; ANTICOAGULANT; CLOPIDOGREL; PREVENTION;

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：187 / 192

页数：6

共 28 条

[1]

*AM COLL CARD AM H, 2007, J AM COLL CARDIOL, V50, pE1

[2]

Anand S, 2007, NEW ENGL J MED, V357, P217

[3]

[Anonymous], LEX COMP DAT

[4]

[Anonymous], FDA APPR EFF RED RIS

[5]

[Anonymous], 2010, PLAV

[6] Pharmacology and management of the vitamin K antagonists [J].

Ansell, Jack ;

Hirsh, Jack ;

Hylek, Elaine ;

Jacobson, Alan ;

Crowther, Mark ;

Palareti, Gualtiero .

CHEST, 2008, 133 (06) :160S-198S

[7] Aspirin dose for the prevention of cardiovascular disease - A systematic review [J].

Campbell, Charles L. ;

Smyth, Susan ;

Montalescot, Gilles ;

Steinhubl, Steven R. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (18) :2018-2024

[8] Combined antiplatelet and anticoagulant therapy: clinical benefits and risks [J].

Eikelboom, J. W. ;

Hirsh, J. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 :255-263

[9]

Furst DE, 2008, BASIC CLIN PHARM, P573

[10] Antiplatelet Therapy in Patients With Anticoagulants Undergoing Percutaneous Coronary Stenting (from STENTIng and oral antiCOagulants [STENTICO]) [J].

Gilard, Martine ;

Blanchard, Didier ;

Helft, Gerard ;

Carrier, Didier ;

Eltchaninoff, Helene ;

Belle, Loic ;

Finet, Gerard ;

Le Breton, Herve ;

Boschat, Jacques .

AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (03) :338-342

← 1 2 3 →